Edition:
United States

Straumann Holding AG (STMN.S)

STMN.S on Swiss Exchange

688.50CHF
8:46am EST
Change (% chg)

CHF-8.00 (-1.15%)
Prev Close
CHF696.50
Open
CHF694.00
Day's High
CHF697.50
Day's Low
CHF684.00
Volume
22,995
Avg. Vol
47,778
52-wk High
CHF746.00
52-wk Low
CHF371.25

Summary

Name Age Since Current Position

Gilbert Achermann

53 2010 Non-Executive Chairman of the Board

Marco Gadola

54 2013 Chief Executive Officer, Member of the Executive Management Board

Thomas Straumann

53 2010 Non-Executive Vice Chairman of the Board of Directors

Peter Hackel

48 2014 Chief Financial Officer, Member of the Executive Management Board

Gerhard Bauer

61 Member of the Executive Management Board, Head Research, Development & Operations

Patrick Loh

2017 Executive Vice President Asia Pacific

Wolfgang Becker

51 Member of the Executive Management Board, Head Distributor and Emerging Markets EMEA

Guillaume Daniellot

47 2016 Member of the Executive Management Board, Head Sales North America

Jens Dexheimer

51 2016 Member of the Executive Management Board, Head Sales Europe

Frank Hemm

47 2013 Member of the Executive Management Board, Head Customer Solutions & Education

Petra Rumpf

50 2015 Member of Executive Management Board, Head Instradent Management & Strategic Alliances

Matthias Schupp

53 2016 Member of the Executive Management Board, Head Sales Latin America, Chief Executive Officer of Neodent

Sebastian Burckhardt

63 Non-Executive Director, Secretary of the Board

Monique Bourquin

2017 Non-Executive Director

Ulrich Looser

60 2010 Non-Executive Director

Beat Luethi

55 2010 Non-Executive Director

Regula Wallimann

2017 Non-Executive Director

Fabian Hildbrand

Head of Corporate Investor Relations

Biographies

Name Description

Gilbert Achermann

Mr. Gilbert Achermann has been Non-Executive Chairman of the Board at Straumann Holding Ltd since April 1, 2010. He holds various mandates in privately- owned and publicly-listed companies across a range of industries, including banking, consumer goods, medical devices, pharma services and retail. In addition to his role as Chairman of Straumann, his activities in 2016 included serving on the Board of Directors of the private bank Julius Baer Group and as an Executive-in-Residence at the IMD Business School in Lausanne. He is also a Business Angel of several start-up companies. In previous years, he served as Chairman and Co-CEO of the Vitra / Vitrashop Group, a family-owned furniture and retail company, Chairman of the Siegfried Group, a listed pharma service company, and Vice Chairman of the Moser Group, a privately-owned luxury watchmaking company. From 2002 to 2010, he was Chief Executive Officer of Straumann, which he joined as Chief Financial Officer in 1998. He started his professional life at UBS in Investment Banking in 1988, working in Switzerland, New York, London and Frankfurt. He holds an Executive MBA from IMD and a bachelor’s degree from the University of St. Gallen.

Marco Gadola

Mr. Marco Gadola has been Chief Executive Officer and Member of the Executive Management Board of Straumann Holding Ltd since March 1, 2013. He previously served as Chief Financial Officer and Executive Vice President Operations from 2006 to 2008, when he left to pursue a career development opportunity at Panalpina. Having started as Panalpina’s Chief Financial Officer, he became Regional CEO Asia/ Pacific in 2012, with overall responsibility for the regional business. Prior to his first term at Straumann, he spent five years at Hero, the Swiss-based international food group, where he was also Chief Financial Officer and responsible for IT and operations. Previously, he spent nine years at the international construction tool manufacturer Hilti, where he held a number of senior commercial/sales and finance-related positions in various countries. Before that, he worked for Sandoz International Ltd, as Audit Manager, and for Swiss Bank Corporation, Basel, in Corporate Finance. He is Vice Chairman of the Board of Calida Group and heads its Audit Committee. He is also Member of the Board of MCH Group, Switzerland, and heads its Audit Committee, in addition to being a panel Member of the Swiss-American Chamber of Commerce. Mr Gadola graduated from Basel University in business administration and economics. He also completed various programs at the London School of Economics and at IMD in Lausanne.

Thomas Straumann

Dr. Thomas Straumann has been Non-Executive Vice Chairman of the Board of Directors of Straumann Holding Ltd since March 26, 2010. He is Member of the Compensation Committee at the Company. In 1990, he was responsible for restructuring Institut Straumann AG and was Chief Executive Officer and Chairman of the Board of Directors until 1994. He was Chairman of the Board of Straumann Holding AG until 2002. In 2004, he was awarded an honorary doctorate by the University of Basel, Switzerland. Dr. Thomas Straumann is the principal shareholder of Straumann Holding AG; he has been a Member of its Board of Directors since 1990. He complements the Board with his understanding of the dental and medical device industries through personal management experience and various shareholdings. Having built up several companies, in which he is still involved, he is a true entrepreneur and has a diverse portfolio of interests, including not-for-profit activities.

Peter Hackel

Dr. Peter Hackel has been Chief Financial Officer and Member of the Executive Management Board at Straumann Holding Ltd since 2014. He rejoined Straumann in 2014, after three years at Oerlikon Industrial Group, where he was Chief Financial Officer of the global segment Oerlikon Drive Systems. He first joined Straumann in 2004 in a Project Management and Business Development role and rose to become Head of Group Controlling and Member of the Corporate Management Group. Prior to Straumann, he spent three years at Geistlich Biomaterials, as Director of Marketing & Sales Orthopaedics, and two years at McKinsey & Company as a Consultant. He obtained both his Master’s degree and Ph.D. in Biochemistry and Molecular Biology from the Swiss Federal Institute of Technology (ETH) in Zurich and complemented his education with studies in Business Administration at the University of Hagen in Germany.

Gerhard Bauer

Dr. Gerhard Bauer serves as Member of the Executive Management Board and Head Research, Development & Operations at Straumann Holding Ltd. He is a seasoned executive with a broad international background in Global Operations. He has spent more than 30 years in the pharmaceutical and medical device industry in various leadership positions. Prior to joining Straumann in 2010, Dr. Bauer held managerial positions at Nextpharma, a specialist company in the biotech industry, and Bausch & Lomb. From 1992 to 2008, his career at Bausch & Lomb was distinguished by increasing responsibility and, in 2006, he was appointed Head of Global Operations & Engineering and Member of the Executive Team. From 1984 to 1992, he worked for Ciba Vision, a subsidiary of Novartis. He began his career in production at GlaxoSmithKline in 1983. Dr. Bauer received his Ph.D. from the Institute of Pharmaceutics at the Ludwig-Maximilians-University in Munich where he also obtained his M.Sc. in Pharmaceutics. Additionally, he received an advanced degree in Pharmaceutical Technology from the Bavarian Chamber of Pharmacists.

Patrick Loh

Wolfgang Becker

Mr. Wolfgang Becker serves as Member of the Executive Management Board and Head Distributor and Emerging Markets EMEA at Straumann Holding Ltd. He rejoined the Company's Executive Management Board as Head Sales Central Europe & Distributors EMEA in 2013. Mr. Becker holds a number of business school diplomas including that of St Gallen Management Center. He began his professional career at Straumann in 1986 and held a series of managerial positions of increasing responsibility in the company’s German subsidiary, becoming Head of Human Resources in 1991, Head of Marketing in 2000, and General Manager of Straumann Germany in 2001. He served on Straumann’s Executive Committee as Head of Sales Europe from 2005 to 2006. Since then, he has been responsible for Straumann’s business in Central and Eastern Europe, and headed the Group’s distributor business from 2007 to 2008.

Guillaume Daniellot

Mr. Guillaume Daniellot has been Member of the Executive Management Board and Head Sales North America of Straumann Holding Ltd since January 1, 2016. Prior to that, he was Member of the Executive Management Board and Head Sales Western Europe at the Company from 2013. Having obtained a Bachelor’s degree in Physics from the University of Dijon and a Masters in Marketing from FGE in Tours, he completed his studies with a Masters in Business Administration at the ESC European School of Management in Paris. His professional career began in hospital product management – initially at Coloplast and then at B. Braun, as an international business unit manager. He switched to the dental industry in 2001, joining Dentsply France, where he became Sales & Marketing Director. Mr. Daniellot joined Straumann in 2007 as Managing Director of Straumann France. Two years later, he transferred to Group Headquarters to become Head of Global Sales Digital Dentistry. Shortly afterwards he took over responsibility for Straumann’s Prosthetic Laboratory Business Group, including global management of sales, marketing, product development, training and education. In both these roles he was a Member of the Corporate Management Group.

Jens Dexheimer

Mr. Jens Dexheimer has been Member of the Executive Management Board and Head Sales Europe at Straumann Holding Ltd since 2016. He is responsible for Straumann’s European region, which includes Austria, Benelux, France, Germany, Iberia, Italy, Scandinavia, Switzerland and the United Kingdom. In his previous positions, he managed the business in Germany and Iberia. In 2016, he was made responsible for the entire Western Europe region and joined the Executive Management Board. He moved to Straumann in 2010 from Wella / Procter & Gamble, which he joined in 1996 and where he rose through various international roles of increasing responsibility from regional Human Resources management to country, divisional and regional leadership. He began his career in consumer goods industry with Benckiser in Germany. Mr. Dexheimer obtained a degree in Economics at the State Vocational Academy in Mannheim (Berufsakademie Mannheim) and a Masters’ Degree from Mainz University. He also completed an Executive Development Program at Kellogg University in Chicago.

Frank Hemm

Mr. Frank Hemm has been Member of the Executive Management Board and Head Customer Solutions & Education of Straumann Holding Ltd since 2013. He was Member of the Executive Management Board and Head of EMEA and LATAM at the Company from 2012. He holds a Master’s degree in Economics from the University of St. Gallen and a Master’s in Business Administration from Kellogg Graduate School of Management in Chicago. His business career began in management consulting with Andersen Consulting and McKinsey, focusing on business process re-engineering and strategic management consulting. He joined Straumann in 2004 and was initially responsible for Corporate Business Development & Licensing. He was appointed Head of Sales, Western Europe in 2007 and became a member of the Corporate Management Group. A year later, he was given responsibility for the Asia / Pacific Region as Head of Sales based in Singapore, where he established and built up Straumann’s regional headquarters. In addition to leading the integration and turnaround of the acquired distributors in Japan and Korea, he also expanded Straumann’s presence in China.

Petra Rumpf

Ms. Petra Rumpf has been Member of Executive Management Board and Head Instradent Management & Strategic Alliances at Straumann Holding Ltd since 2015. She worked for Nobel Biocare from 2007 to 2014, where she was Member of the Executive Committee and responsible for Corporate Development and M&A, global e-commerce, clinical training & education, and the development of the distributor business. She also managed the initiation of the Foundation for Oral Rehabilitation (FOR), a global foundation that is active in the area of science, education and humanity. During her last three years with the company, Petra Rumpf was also responsible for AlphaBio Tec – which is active in more than 50 countries, guiding its expansion into China and emerging markets. Before joining Nobel Biocare, she spent 16 years at Capgemini Consulting, where she rose through various managerial roles to become Vice President Strategy & Transformation Consulting. Her work covered a spectrum of countries and industries with a focus on life sciences and high-tech. She holds an MBA from the Clark University in Worcester (USA) and a BA in economics from the Trier University in Germany.

Matthias Schupp

Mr. Matthias Schupp has been Member of the Executive Management Board, Head Sales Latin America and Chief Executive Officer of Neodent at Straumann Holding Ltd since 2016. He joined Straumann from Procter & Gamble in 2007 as Regional Manager, Western Europe. In 2013, he was appointed Head of Sales for the LATAM region and joined the management of Neodent, of which he became Chief Executive Officer early in 2015. Mr Schupp has a track record in country / regional management in various industries. He began his career in marketing and customer service with Merck KGaA, the German pharmaceuticals, fine chemicals and diagnostics company, and rose through country management to the position of Regional Manager Latin America and United States. He moved to Wella in 2000 as Managing Director of the business in Russia and became Managing Director Professional Care Portugal in 2004, following the acquisition of Wella by P & G. Having graduated at the German / Brasilian High School in Rio de Janeiro, he gained most of his training in Business Administration and Management on the job through managerial and professional development programs at Merck and P & G.

Sebastian Burckhardt

Dr. Sebastian Burckhardt is Non-Executive Director and Secretary of the Board at Straumann Holding Ltd. He has been Non-Executive Director at the Company since 2002. Additionally, he acts as Member of the Audit Committee of the Company. He began his studies in the fields of economics and law and obtained his doctorate law degree at the University of Basel. He is a lawyer admitted to the Bar of Switzerland and a civil law notary in Basel. He is a specialist in corporate and commercial law and in mergers, acquisitions, joint ventures, licensing, distribution and technology agreements. His knowledge extends well beyond legal matters and includes many years’ experience on corporate boards.

Monique Bourquin

Ulrich Looser

Mr. Ulrich Looser has been Non-Executive Director at Straumann Holding Ltd since April 1, 2010. He is Chairman of the Compensation Committee and Member of the Audit Committee at the Company. He is a Partner of BLR & Partners AG. From 2001 to 2009, he was with Accenture Ltd, where he became Chairman of its Swiss affiliate (2005) and Managing Director of the Products Business in Austria, Switzerland and Germany. Earlier, he spent six years as a partner at McKinsey & Company Ltd. Mr. Looser graduated in physics at the Swiss Federal Institute of Technology (ETH), Zurich, and in economics at the University of St. Gallen.

Beat Luethi

Dr. Beat E. Luethi has been Non-Executive Director at Straumann Holding Ltd since April 1, 2010. He is Member of the Compensation Committee at the Company. He is Chief Executive Officer and co-owner of CTC Analytics AG, Zwingen, a globally active medium-sized Swiss company in the field of chromatography automation. After obtaining his Ph.D. in Engineering from the Swiss Federal Institute of Technology (ETH), Zurich, he began his career with Zellweger Uster AG, a manufacturer of quality control equipment in textile production. In 1990, he moved to Mettler-Toledo International Inc and rose to the position of General Manager of the Swiss affiliate. In 1994, he completed an executive program at INSEAD and subsequently joined the Feintool Group in 1998. During his four-year tenure as Chief Executive Officer, the company went public and doubled in size. In 2003, he returned to Mettler-Toledo as Chief Executive Officer of the Laboratory Division. At the end of 2007, he joined CTC Analytics to lead and further develop the company as an entrepreneur.

Regula Wallimann

Fabian Hildbrand